Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PDE11A Antikörper (C-Term)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch PDE11A in ELISA, WB, IHC, IF, IP, ICC und CM. Er zeigt eine Reaktivität gegenüber Human, Maus und Ratte und wurde in 7+ Publikationen erwähnt.
Produktnummer ABIN2747057

Kurzübersicht für PDE11A Antikörper (C-Term) (ABIN2747057)

Target

Alle PDE11A Antikörper anzeigen
PDE11A (phosphodiesterase 11A (PDE11A))

Reaktivität

  • 31
  • 23
  • 20
  • 5
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 33
  • 1
Kaninchen

Klonalität

  • 34
Polyklonal

Konjugat

  • 15
  • 8
  • 7
  • 2
  • 1
  • 1
Dieser PDE11A Antikörper ist unkonjugiert

Applikation

  • 28
  • 26
  • 18
  • 14
  • 11
  • 9
  • 8
  • 2
ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP), Immunocytochemistry (ICC), Confocal Microscopy (CM)
  • Bindungsspezifität

    • 8
    • 6
    • 6
    • 6
    • 5
    • 5
    • 5
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 420-480, C-Term

    Aufreinigung

    Affinity Purified

    Immunogen

    Synthetic peptide taken within amino acid region 420-480 on PDE11A protein, common to all PDE11A variants.

    Isotyp

    IgG
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.69 μg/μL
  • Kelly: "Does phosphodiesterase 11A (PDE11A) hold promise as a future therapeutic target?" in: Current pharmaceutical design, Vol. 21, Issue 3, pp. 389-416, (2015) (PubMed).

    Kelly, Adamowicz, Bove, Hartman, Mariga, Pathak, Reinhart, Romegialli, Kleiman: "Select 3',5'-cyclic nucleotide phosphodiesterases exhibit altered expression in the aged rodent brain." in: Cellular signalling, Vol. 26, Issue 2, pp. 383-97, (2014) (PubMed).

    Hamilton, Hu, Kolomitro, Bell, Maurice, Graham, Siemens: "Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer." in: World journal of urology, Vol. 31, Issue 2, pp. 325-30, (2013) (PubMed).

    Genders, Bradley, Rattigan, Richards: "cGMP phosphodiesterase inhibition improves the vascular and metabolic actions of insulin in skeletal muscle." in: American journal of physiology. Endocrinology and metabolism, Vol. 301, Issue 2, pp. E342-50, (2011) (PubMed).

    Kruse, Møller, Tibaek, Gammeltoft, Olesen, Kruuse: "PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system." in: Brain research, Vol. 1281, pp. 25-34, (2009) (PubMed).

    Baxendale, Fraser: "Mammalian sperm phosphodiesterases and their involvement in receptor-mediated cell signaling important for capacitation." in: Molecular reproduction and development, Vol. 71, Issue 4, pp. 495-508, (2006) (PubMed).

    DAndrea, Qiu, Haynes-Johnson, Bhattacharjee, Kraft, Lundeen: "Expression of PDE11A in normal and malignant human tissues." in: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, Vol. 53, Issue 7, pp. 895-903, (2005) (PubMed).

  • Target

    PDE11A (phosphodiesterase 11A (PDE11A))

    Andere Bezeichnung

    PDE11A

    UniProt

    Q9HCR9

    Pathways

    cAMP Metabolic Process
Sie sind hier:
Chat with us!